Management of liver metastases: New horizons for biologically based therapy

Journal of Surgical Research

Volumn 117, Issue 1, 2004, Pages 144-153

  Allendorf, John ^a,b   Ippagunta, Nikalesh ^a   Emond, Jean ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 3 (4 BROMO 2,6 DIFLUOROBENZYLOXY) 5 [3 [4 (1 PYRROLIDINYL)BUTYL]UREIDO] 4 ISOTHIAZOLECARBOXAMIDE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BATIMASTAT; BRYOSTATIN 1; CAMPTOTHECIN; CYTOSINE DEAMINASE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MARIMASTAT; METALLOPROTEINASE INHIBITOR; MM 1270; N (4 BROMO 2 FLUOROPHENYL) 6 METHOXY 7 [2 (1H 1,2,3 TRIAZOL 1 YL)ETHOXY] 4 QUINAZOLINAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; ONCOLYTIC VIRUS; ONYX 015; OXALIPLATIN; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN P53; RECOMBINANT PROTEIN; SEMAXANIB; SULINDAC; THYMIDINE KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VASCULOTROPIN ANTIBODY; VIRUS VECTOR;

ANGIOGENESIS; ANTIGEN PRESENTING CELL; APOPTOSIS; BIOLOGICAL THERAPY; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL MOTILITY; CLINICAL TRIAL; COLORECTAL CANCER; CRYOSURGERY; DENDRITIC CELL; DRUG BIOAVAILABILITY; DRUG MEGADOSE; DRUG SOLUBILITY; DRUG TARGETING; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEPATIC ARTERY; HUMAN; IMMUNOTHERAPY; LAPAROSCOPY; LIVER METASTASIS; LIVER RESECTION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; RADIOFREQUENCY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; SUICIDE GENE; TARGET CELL; VACCINATION; VIRUS REPLICATION;

EID: 1542358193     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2003.11.003     Document Type: Article

References (87)

1. Landis S.H., Murray T., Bolden S. Cancer statistics, 1999. CA Cancer J. Clin. 1:1999;8.
2. Jaffe B.M., Donegan W.L., Watson F. Factors influencing survival in patients with untreated hepatic metastases. Surg.Gynecol. Obstet. 127:1968;1.
3. Bengtsson G., Carlsson G., Hafstrom L., Jonsson P.E. Natural history of patients with untreated liver metastases from colorectal cancer. Am.J. Surg. 141:1981;586.
4. Cromheecke M., DeJong K.P., Hoekstra H.J. Current treatment for colorectal cancer metastatic to the liver. Eur.J. Surg. Oncol. 25:1999;451.
5. Wilson S.M., Adson M.A. Surgical treatment of hepatic metastases from colorectal cancers. Arch. Surg. 111:1976;330.
6. Fong Y., Fortner J., Sun R., Brennan M., Blumgart L.H. Clinical score or predicting recurrence after hepatic resection for metastatic colorectal cancer Analysis of 1001 consecutive cases. Ann. Surg. 230:1999;309.
7. Butler J., Attiyeh F.F., Daly J.M. Hepatic resection for metastases of the colon and rectum. Surg. Gynecol. Obstet. 162:1986;109.
8. Fortner J.G., Silva J.S., Golbey R.B. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann. Surg. 199:1984;306.
9. Pagana T.J. A new technique for hepatic artery infusion chemotherapy. Semin. Surg. Oncol. 2:1986;99.
10. Hughes K.S., Rosenstein R.B., Songhorabodi S. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long term survivors. Dis. Colon Rectum. 31:1988;1.
11. Kemeny N., Huang Y., Cohen A.M., Shi W., Conti J.A., Brennan M.F., Bertino J.R., Turnbull A.D.M., Sullivan D., Stockman J., Blumgart L.H., Fong Y. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N. Engl. J. Med. 341:1999;2039.
12. Curley S.A. New approaches to the treatment of hepatic metastases. Radiofrequency ablation of malignant liver tumors. Ann. Surg. Oncol. 10:2003;338.
13. Butler T., Gullino P. Quantitation of cell shedding into efferent blood vessels of mammary adeno carcinoma. Cancer Res. 35:1975;572.
14. Hynes R.O. Integrins Bidirectional, allosteric signaling machines. Cell. 110:2002;673.
15. Raftopoulos I., Davaris P., Karatzas G., Karayannacos P., Kouraklis G. Level of α-catenin expression in colorectal cancer correlates with invasiveness, metastatic potential and survival. J.Surg. Oncol. 68:1998;92.
16. D'Amato M., Flugy A.M., Alaimo G., Bauder B., Kohn E.C., De Leo G., Alessandro R. Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells. Biochem. Biophys. Res. Commun. 301:2003;907.
17. Benchimol S., Fuks A., Jothy S. Carcino embrionic antigen a human tumor marker, functions as an intercellular adhesion molecule. Cell. 57:1989;327.
18. McCawley C.J., Matri Sian L.M. Matrix metallo proteinases, they are just not for matrix anymore. Curr. Opin. Cell Biol. 13:2001;534.
19. Murphy G., Docherty A.J.P. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7:1992;120.
20. Tryggvason K., Höyhtä M., Pyke M. Type IV collagenases in invasive tumors. Breast Cancer Res.Treat. 24:1993;209.
21. Masaki T., Matsuoka H., Sugiyama M., Abe N., Goto A., Sakamoto A., Atomi Y. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br.J. Cancer. 84:2001;1317.
22. Chapman H.A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Biol. 9:1997;714.
23. Dano K., Romer J., Nielsen B.S., Bjorn S., Pyke C., Rygaard J., Lund L.R. Cancer invasion and tissue remodeling - Cooperation of protease systems and cell types. Apmis. 107:1999;120.
24. Fujita S., Sugano K. Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. Jpn. J. Clin. Oncol. 27:1997;378.
25. Folkman J., Merler E., Abernathy C., Williams G. Isolation of a tumor factor responsible or angiogenesis. J. Exp. Med. 133:1971;275.
26. Cassano A., Bagala C., Battelli C., Schinzari G., Quirino M., Ratto C., Landriscina M., Barone C. Expression of vascular endothelial growth factor, mitogen-activated protein kinase and p53 in human colorectal cancer. Anticancer Res. 22:2002;2179.
27. Takahashi Y., Kitadai Y., Bucana C.D. Expression of vascular endothelial growth factor and its receptor, KDR correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55:1995;3964.
28. Ahmad S.A., Liu W., Jung Y.D., Fan F., Wilson M., Reinmuth N., Shaheen R.M., Bucana C.D., Ellis L.M. The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer. Cancer Res. 61:2001;1255.
29. Mendelsohn J., Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 19:2000;6550.
30. Berman R.S., Portera C.A., Ellis L.M. Biology of liver metastases. Talamonti M. Liver-Directed Therapy for Primary and Metastatic Liver Tumors. 2001;1-29 Kluwer Academic Publishers, Boston.
31. Berman R.S., Sweeney B., McConkey D.J. Metastatic colorectal cancer cells are resistant to anoikis, inducing Akt phosphorylation (A2162). Am. Cancer Soc. 40:1999;326. Proceedings of the 90th Annual Meeting of the American Association for Cancer Research. New Orleans (LA).
32. Fisher B., Fisher E. Experimental studies of factors influencing hepatic metastases II. Effect of partial hepatectomy. Cancer. 12:1959;929.
33. Gershbein L.L. Transplanted tumor growth and liver regeneration in the rat. J. Natl. Cancer Inst. 31:1963;521.
34. Rosene G.L. Alteration of tumor cell and hepatic parenchyma cell mitotic rates in tumor-injected partially hepatectomized mice. Cancer Res. 28:1968;1469.
35. Asaga T., Suzuki K., Umeda M., Sugimasa Y., Takemiya S., Okamoto T. The enhancement of tumor growth after partial hepatectomy and the effect of sera obtained from hepatectomized rats on tumor cell growth. Jpn. J. Surg. 21:1991;669.
36. Ikeda Y., Matsumata T., Takenaka K., Sasaki O., Soejima K., Sugimachi K. Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur. J. Surg. Oncol. 21:1995;188.
37. Ichihashi H., Mabuchi H., Suenaga M., Kondo T. Liver regeneration and tumor growth in the rat after partial hepatectomy. Jpn. J. Surg. 13:1984;510.
38. Seglen P.O., Saeter G., Schwarze P.E. Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas. Hepatology. 12:1990;295.
39. Leith J.T., Padfield G., Michelson S. Effects of partial hepatectomy on the growth characteristics of the hypoxic fractions of xenografted DLD-2 human colon cancers. Radiat. Res. 132:1992;263.
40. Panis Y., Ribeiro J., Chertien Y., Nordlinger B. Dormant liver metastases An experimental study. Br. J. Surg. 79:1992;221.
41. de Jong K.P., Lont H.E., Bijma A.M., van Veen M.L., Brouwers M.A.M., de Vries E.G.E., Marquet R.L., Sloof M.J.H., Terpstra O.T. The effect of partial hepatectomy on tumor growth in rats In vivo and in vitro studies. Hepatology. 22:1995;1263.
42. Marti U., Burwen S.J., Jones A.L. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver An update. Hepatology. 9:1989;126.
43. Olsen P.S., Boesby S., Kirkegaard P., Therkelsen K., Almdal T., Puolsen S.S., Nexo E. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology. 8:1988;992.
44. Mead J.E., Fausto N. Transforming growth factor alpha may be a physiologic regulator of liver regeneration by means of an autocrine mechanism. Proc. Natl. Acad. Sci. USA. 86:1989;1558.
45. Radinsky R., Risin S., Fan D., Dong Z., Bielenberg D., Bucana C.D., Fidler I.J. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin. Cancer Res. 1:1995;19.
46. Derynck R., Goeddel D.V., Ullrich A., Gutterman J.U., Williams R.D., Bringman T.S., Berger W.H. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res. 47:1987;707.
47. Braun L., Mead J.E., Panzica M., Mikumo R., Bell G.I., Fausto N. Transforming growth factor beta mRNA increases during liver regeneration A possible paracrine mechanism of growth regulation. Proc. Natl. Acad. Sci. USA. 85:1988;1539.
48. Hoosein N.M., McKnight M.K., Levine A.E., Mulder K.M., Childress K.E., Brattain D.E., Brattain M.G. Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor beta 1. Exp. Cell. Res. 181:1989;442.
49. Lahm H., Petral-Malec D., Yilmaz-Ceyhan A., Fischer J.R., Lorenzoni M., Givel J.C., Odartchenko N. Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1. Eur. J. Cancer. 28A:1992;1894.
50. Scott C.D., Baxter R.C. Insulin-like growth factor-II/manose-6-phosphate receptors are increased in hepatocytes from regenerating rat liver. Endocrinology. 126:1990;2543.
51. Caro J.F., Poulos J., Ittoop O., Pories W.J., Flickinger E.G., Sinha M.K. Insulin-like growth factor binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J. Clin. Invest. 81:1988;976.
52. Tricoli J.V., Rall L.B., Karakousis C.P., Herrera L., Petrelli N.J., Bell G.I., Shows T.B. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res. 46:1986;6169.
53. Durrant L.G., Watson S.A., Hall A., Morris D.L. Co-stimulation of gastrointestinal tumor cell growth by gastrin, transforming growth factor alpha, and insulin like growth factor-I. Br. J. Cancer. 63:1991;67.
54. Kinoshita T., Hirao S., Matsumoto K., Nakamura T. Possible endocrine control by hepatocyte growth factor of liver regeneration after partial hepatectomy. Biochem. Biophys. Res. Commun. 177:1991;330.
55. Lindroos P.M., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in the plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 13:1991;743.
56. Suntitha I., Meighen D.L., Hartman D.P., Thompson E.W., Byers S.W., Avigan M.I. Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line. Clin. Exp. Metastases. 12:1994;143.
57. Di Renzo M.F., Narsimhan R.P., Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P.M. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 6:1991;1997.
58. Shirota K., LeDuy L., Yuan S.Y., Jothy S. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch. B Cell Pathol. 58:1990;303.
59. Fearon K.C., McMillan D.C., Preston T., Winstanley F.P., Cruickshank A.M., Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann. Surg. 213:1991;26.
60. Avery A., Paraskeva C., Hall P., Flanders K.C., Sporn M., Moorghen M. TGF-beta expression in the human colon Differential immunostaining along crypt epithelium. Br. J. Cancer. 68:1993;137.
61. Satoh M., Yamazaki M. TNF-driven inflammation during mouse liver regeneration after partial hepatectomy and its role in growth regulation of liver. Mol. Biother. 3:1991;136.
62. Beyer H.S., Stanley M., Theologides A. Tumor necrosis factor alpha increases hepatic DNA and RNA and hepatocyte mitosis. Biochem. Int. 22:1990;405.
63. Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J., Diehl A.M. Antibodies to tumor necrosis alpha inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263:1992;G579.
64. Thomas C., Nijenhuis A.M., Dontje B., Daemen T., Scherphof G.L. Tumoricidal response of liver macrophages isolated from rats bearing liver metastases of colon adenocarcinoma. J. Leukoc. Biol. 57:1995;617.
65. Bouwens L., Baekeland M., Wisse E. Importance of local proliferation in the expanding Kupffer cell population of rat liver zymosan stimulation and partial hepatectomy. Hepatology. 4:1984;21309.
66. Ukai K., Terashima K., Imai Y., Shinzawa H., Okuyama Y., Takahashi T., Ishikawa M. Proliferation kinetics of rat Kupffer cells after partial hepatectomy. Immunohistochemical and ultrastructural analysis. Acta Pathol. Jpn. 40:1990;623.
67. Roh M.S., Kahky M.P., Oyedeji C., Klostergaard J., Wanf L., Curley S.A., Lotzova E. Murine Kupffer cells and hepatic natural killer cells regulate tumor growth in a quantitative model of colorectal liver metastases. Clin. Exp. Metastasis. 10:1992;317.
68. Katsumoto F., Miyazaki K., Nakayama F. Stimulation of DNA synthesis in hepatocytes by Kupffer cells after partial hepatectomy. Hepatology. 9:1989;405.
69. Roh M.S., Wang L., Oyedeji C., LeRoux M.E., Curley S.A., Pollock R.E., Klostergaard J. Human Kupffer cells are cytotoxic against human colon adenocarcinoma. Surgery. 108:1990;400.
70. Bouwens L., Wisse E. Pit cells in the liver. Liver. 12:1992;3.
71. Bouwens L., Charles K., van Dale P., Wisse E. Sinusoidal cell reactions associated with colon cancer metastases in rat liver. Knook D.L., Wisse E. Cells of the Hepatic Sinusoid II. 1989;237-238 Rijswijk, Kupffer Cell Foundation.
72. Roshen P.J., Amado R., Hecth J.R. A phase I/II study of SU5416 in combination with 5FU/leucovorin in patients with metastatic colorectal cancer[abstract 5D] Proceedings of American society of Clinical Oncology. 2000;ASCO publication, New Orleans.
73. Tokunaga T., Nakamura M., Oshika Y. Thrombospondin 2 expression is correlated with inhibition of angiogenesis and metastasis of colon cancer. Br. J. Cancer. 79:1999;354.
74. De B., Natchus M.G., Cheng M., Pikul S., Almstead N.G., Taiwo Y.O., Snider C.E., Chen L., Barnett B., Gu F., Dowty M. The next generation of MMP inhibitors. Design and synthesis. Ann. NY Acad. Sci. 878:1999;40.
75. Meyers M.O., James C. Watson angiogenesis and hepatic colorectal metastasis. Surg. Oncol. Clin. N. Am. 12:2003;151.
76. Burke C.A., Bauer W.M., Lashner B. Chemoprevention of colorectal cancer slow, steady progress. Cleve. Clin. J. Med. 70:2003;346.
77. Ahmad S., Berman R.S., Ellis L.M. Biology of colorectal liver metastasis. Surg. Oncol. Clin. N. Am. 12:2003;135.
78. Gunzburg W., Fleuchaus A., Saller R. Retroviral vector targeting for gene therapy. Cytokines Mol. Ther. 2:1996;177.
79. Sikorski R., Peter R. Gene therapy Treating with HIV. Science. 282:1998;1438.
80. Nabel E., Gordon D., Yang Z. Gene transfer in vivo with DNA liposome complex. Hum. Gene Ther. 3:1992;649.
81. Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell. 70:1992;523.
82. Maron D.J., Choi E.A., Spitz F.R. Gene therapy of metastatic disesase. Surg. Oncol. Clin. N. Am. 10:2001;448.
83. Donahue J.M., Mullen J.T., Tanabe K.K. Viral oncolysis. Surg. Oncol. Clin. N. Am. 11:2002;661.
84. Reid T., Warren R., Kirn D. Intravascular adenoviral agents in cancer patients Lessons from clinical trials. Cancer Gene Ther. 9:2002;979.
85. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Ann. Rev. Immunol. 18:2000;767.
86. Kugler A., Stuhler G., Walden P. Regression of human metastatic renal cell carcinoma after vaccination with tumor dendritic cell hybrids. Nat. Med. 6:2000;332.
87. Moroi Y., Mayhew M., Trcka J. An induction of cellular immunity by immunisation with novel hybrid peptides complexed to heat shock protein 70. Proc. Natl. Acad. Sci. USA. 97:2000;3485.